Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Cash & Current Investments (2016 - 2025)

Immuron (IMRN) posted quarterly Cash & Current Investments of $28305.3 for Q3 2025, down 75.72% year-over-year from $116573.2 in Q3 2024, and down 98.44% quarter-over-quarter from $1.8 million in Q2 2025.

Immuron (IMRN) Cash & Current Investments (2016 - 2025) Analysis & Trends

Immuron's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $28305.3 for Q3 2025.

  • In Q3 2025, Cash & Current Investments fell 75.72% year-over-year to $28305.3; the TTM figure through Sep 2025 stood at $28305.3 (down 75.72% YoY), while the FY2025 annual figure was $11.7 million, down 32.07% from the prior year.
  • Cash & Current Investments for Q3 2025 stood at $28305.3, down from $1.8 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $19.3 million in Q2 2021, with the low at $28305.3 in Q3 2025.
  • The 5-year median for Cash & Current Investments is $9.5 million (2024), against an average of $9.3 million.
  • The sharpest annual moves came in 2021 and 2023: Cash & Current Investments soared 6833.34% in 2021, then tumbled 98.88% in 2023.
  • Immuron's Cash & Current Investments stood at $18.3 million in 2021, then fell by 20.77% to $14.5 million in 2022, then decreased by 14.81% to $12.4 million in 2023, then sank by 38.4% to $7.6 million in 2024, then sank by 99.63% to $28305.3 in 2025.
  • Business Quant data shows IMRN's Cash & Current Investments at $28305.3 in Q3 2025, $1.8 million in Q2 2025, and $7.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Immuron 6.75 Mn 6.73 Mn - 28,305.26

Historic Data

Download Data
DateValue
Sep 2, 2025 28,305.26
Jun 30, 2025 1.81 Mn
Dec 31, 2024 7.62 Mn
Sep 9, 2024 116,573.15
Jun 30, 2024 7.68 Mn
Dec 31, 2023 12.38 Mn
Sep 28, 2023 11.25 Mn
Aug 30, 2023 171,597.64
Jun 30, 2023 6.00 Mn
Dec 31, 2022 14.53 Mn
Aug 31, 2022 15.38 Mn
Jun 30, 2022 15.84 Mn
Dec 31, 2021 18.34 Mn
Jun 30, 2021 19.29 Mn
Dec 31, 2020 264,447.68
Sep 1, 2020 3.25 Mn
Jun 30, 2020 2.13 Mn
Dec 31, 2019 5.12 Mn
Jun 30, 2019 3.59 Mn
Dec 31, 2018 4.19 Mn